Reports
Sale
Global Chronic Renal Failure Therapeutic Market Size, Report: By Product: Antihypertensive Therapeutics, Antianemia Therapeutics, Others, Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; 2024-2032
Global Chronic Renal Failure Therapeutic Market Outlook
The global chronic renal failure therapeutic market size is expected to grow at a CAGR of 6% in the forecast period of 2024-2032. The industry has witnessed a substantial growth in the recent years across the world in both developing and developed countries.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
Chronic kidney failure or chronic renal failure involves the loss of kidney functions over a prolonged period of time as opposed to acute renal failure. Stage 6 is for patients with a glomerular filtration rate of less than 15 mL per minute. For their renal failure, dialysis intervention is required.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be divided based on segments like the product types and regions. The industry can be broadly categorised on the basis of product into:
- Antihypertensive Therapeutics
- Antianaemia Therapeutics
- Others
The EMR report looks into the regional markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
Cardiovascular and metabolic conditions are the major risk factors for chronic renal failure. The increased prevalence of these risk factors leads to a significant increase in chronic renal disease incidence. Most of the market for this disorder is from the geriatric population in the United States, Europe, and Asia. Throughout the forecast period, the growing prevalence of chronic renal failure will consequently increase the growth prospects of the industry for chronic renal failure therapeutic. Developing novel inhibitors of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) will also accelerate the industry growth for chronic renal failure therapies. For patients without haemodialysis, oral administration of HIF-PH drugs is preferable. Such factors raise the demand for these medications, leading to the expansion of the global therapeutic market for chronic renal failure.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global chronic renal failure therapeutic market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Amgen Inc. (NASDAQ: AMGN)
- AstraZeneca Plc
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- Pfizer Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Chronic Renal Failure Therapeutic Market Analysis
8.1 Key Industry Highlights
8.2 Global Chronic Renal Failure Therapeutic Historical Market (2018-2023)
8.3 Global Chronic Renal Failure Therapeutic Market Forecast (2024-2032)
8.4 Global Chronic Renal Failure Therapeutic Market by Product
8.4.1 Antihypertensive Therapeutics
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Antianemia Therapeutics
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Others
8.5 Global Chronic Renal Failure Therapeutic Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
9 North America Chronic Renal Failure Therapeutic Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Chronic Renal Failure Therapeutic Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Chronic Renal Failure Therapeutic Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Chronic Renal Failure Therapeutic Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Chronic Renal Failure Therapeutic Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Amgen Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 AstraZeneca PLC
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Pfizer Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 F. Hoffmann-La Roche Ltd
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Bayer AG
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Chronic Renal Failure Therapeutic Market: Key Industry Highlights, 2018 and 2032
2. Global Chronic Renal Failure Therapeutic Historical Market: Breakup by Product (USD Million), 2018-2023
3. Global Chronic Renal Failure Therapeutic Market Forecast: Breakup by Product (USD Million), 2024-2032
4. Global Chronic Renal Failure Therapeutic Historical Market: Breakup by Region (USD Million), 2018-2023
5. Global Chronic Renal Failure Therapeutic Market Forecast: Breakup by Region (USD Million), 2024-2032
6. North America Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
7. North America Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
8. Europe Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
9. Europe Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Asia Pacific Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
11. Asia Pacific Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Latin America Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
13. Latin America Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Middle East and Africa Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
15. Middle East and Africa Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Global Chronic Renal Failure Therapeutic Market Structure
Key Questions Answered in the Report
The global chronic renal failure therapeutic market is projected to grow at a CAGR of 6% between 2023 and 2032.
The major drivers of the industry, such as the growing incidences of chronic renal failure, changing lifestyle and consumption patterns, increasing geriatric population, and the growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the development of hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitors and the growing R&D activities.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Antihypertensive and antianaemia therapeutics, among others, are the leading products of chronic renal failure therapeutic in the industry.
The major players in the industry are Amgen Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Bayer AG, and Pfizer Inc., among others.
Analyst Review
The global chronic renal failure therapeutic market is being driven by the rising prevalence of cardiovascular disorders, which leads to chronic renal failure. Aided by the development of novel oral HIF-PH inhibitors, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the industry can be segmented into antihypertensive, and antianaemia therapeutics, among others. The major regional markets for chronic renal failure therapeutic are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Amgen Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Bayer AG, and Pfizer Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER